Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia

NCT05778591 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05778591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05778591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Recruiting
Start date
May 17, 2024
Completion date
March 1, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia